User profiles for Rashan Haniffa
 | Rashan HaniffaUniversity of Edinburgh, University College Hospital London, KDU Hospital Sri Lanka, NICS … Verified email at ed.ac.uk Cited by 7651 |
[PDF][PDF] Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future
In many low-and middle-income countries (LMICs), with improved public health services
like sanitation and immunization, the relative importance of curative care to improve health …
like sanitation and immunization, the relative importance of curative care to improve health …
[HTML][HTML] Recommendations for sepsis management in resource-limited settings
Purpose To provide clinicians practicing in resource-limited settings with a framework to
improve the diagnosis and treatment of pediatric and adult patients with sepsis. Methods The …
improve the diagnosis and treatment of pediatric and adult patients with sepsis. Methods The …
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
…, LJ Estcourt, M Fitzgerald, H Goossens, R Haniffa… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
…, M Fitzgerald, H Goossens, C Green, R Haniffa… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
[HTML][HTML] Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review
Background Prognostic models—used in critical care medicine for mortality predictions, for
benchmarking and for illness stratification in clinical trials—have been validated …
benchmarking and for illness stratification in clinical trials—have been validated …
Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low …
…, MW Dünser, MA Faiz, DS Grant, R Haniffa… - Jama, 2018 - jamanetwork.com
… ; Saroj Jayasinghe, MD, PhD, University of Colombo, Sri Lanka, National Hospital of Sri
Lanka, Colombo, Sri Lanka, and Faculty of Medicine, Colombo, Sri Lanka; Aasiyah Rashan, …
Lanka, Colombo, Sri Lanka, and Faculty of Medicine, Colombo, Sri Lanka; Aasiyah Rashan, …
Critical care bed capacity in Asian countries and regions
Objective: To assess the number of adult critical care beds in Asian countries and regions in
relation to population size. Design: Cross-sectional observational study. Setting: Twenty-…
relation to population size. Design: Cross-sectional observational study. Setting: Twenty-…
[HTML][HTML] Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global …
Background WHO has established a Global Clinical Platform for the clinical characterisation
of COVID-19 among hospitalised individuals. We assessed whether people living with HIV …
of COVID-19 among hospitalised individuals. We assessed whether people living with HIV …
[HTML][HTML] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …
